Quality standard

Quality statements

Quality statements

Statement 1 People with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist.

Statement 2 People with Cambridge Prognostic Group (CPG) 1 localised prostate cancer for whom radical treatment is suitable are offered active surveillance.

Statement 3 People with Cambridge Prognostic Group (CPG) 2, 3, 4 and 5 localised or locally advanced prostate cancer who are offered non-surgical radical treatment are offered radical radiotherapy and androgen deprivation therapy in combination.

Statement 4 People with adverse effects of prostate cancer treatment are referred to specialist services.

Statement 5 People with hormone-relapsed metastatic prostate cancer have their treatment options discussed by the urological cancer multidisciplinary team.